DEFERRED FINANCING FEES	12 Months Ended
Dec. 31, 2015
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
DEFERRED FINANCING FEES	Deferred financing fees result from the issuance of share warrants as finders’ fees in connection with flow-through financing completed on December 23, 2013. The fair value of the warrants amounted to $25,431 and was determined using the Black-Scholes option–pricing model. The deferred financing fees are being amortized over the life of the warrants which is 2 years. Amortization of deferred financing fees for the years ended December 31, 2015 and 2015 was $12,366 and $13,065. Breathe assumed this asset as part of the reverse merger. As of December 31, 2015 the fees have been fully amortized.

DEFERRED FINANCING FEES

12 Months Ended

Dec. 31, 2015

Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]

Deferred financing fees result from the issuance of share warrants as finders’ fees in connection with flow-through financing completed on December 23, 2013. The fair value of the warrants amounted to $25,431 and was determined using the Black-Scholes option–pricing model. The deferred financing fees are being amortized over the life of the warrants which is 2 years. Amortization of deferred financing fees for the years ended December 31, 2015 and 2015 was $12,366 and $13,065. Breathe assumed this asset as part of the reverse merger. As of December 31, 2015 the fees have been fully amortized.